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Background: Right-sided colon cancer is considered to be biologically different from left-sided colon
cancer; however, conﬂicting results have been reported regarding differences in prognosis. We aimed to
clarify the prognostic impact of tumor location in stage IV colon cancer. Methods: Stage IV colon cancer
treated from January 1997 to December 2007 (n ¼ 2208) were retrospectively studied. Clinical and
pathological features were compared between right-sided colon cancer (cecum, ascending, and trans-
verse colon) and left-sided colon cancer (descending, sigmoid, and rectosigmoid colon). The impact of
tumor location on cancer-speciﬁc survival (CSS) was analyzed in a multivariate analysis and propensity
score analysis to mitigate the differences in background features. Results: Right-sided colon cancer was
associated with older age, female sex, larger tumor size, poorly differentiated adenocarcinoma, mucinous
adenocarcinoma, and signet-ring cell carcinoma, a more advanced state within stage IV disease, and a
worse CSS. In the cohort matched by propensity scores for background clinicopathological features,
tumor location in the right-sided colon was associated with a signiﬁcantly worse CSS (hazard ratio 1.2,
95% conﬁdence interval 1.1e1.4, p ¼ 0.008) in patients treated with palliative primary tumor resection,
but not in those treated with R0 resection or no resection. Conclusion: Right-sided colon cancer were
diagnosed at a more advanced state within stage IV disease and showed a signiﬁcantly worse prognosis
than left-sided colon cancer, suggesting that stage IV right-sided colon cancer is oncologically more
aggressive than left-sided colon cancer.
© 2014 Surgical Associates Ltd. Published by Elsevier Ltd. All rights reserved.S. Ishihara), toshwatanabe@
by Elsevier Ltd. All rights reserved1. Introduction
Colorectal cancer is the second leading cause of cancer-related
deaths in the United States [1] and the third in Japan [2]. Despite
the widespread screening for early detection of colorectal cancer,
approximately 15%e20% of patients with colorectal cancer are.
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of stage IV colorectal cancer is still challenging in spite of the recent
advances in surgery and chemotherapy; therefore, the under-
standing of prognostic factors in stage IV colorectal cancer is
important for the improvement of the therapeutic options for in-
dividual patients.
Recently, there has been an increase in the percentage of right-
sided colon cancer compared with the left-sided cancer in both
eastern and western countries [5,6]. The colonic segment proximal
to the splenic ﬂexure (right-sided colon) and the distal segment
(left-sided colon) are of embryologically different origins, the
former develops from the midgut and the latter from the hindgut;
further, they are physiologically different [7]. Tumors that arise in
these two colonic segments have been shown to have different
clinical and pathological features and their carcinogenetic path-
ways have been suggested to differ [7e11]; further, conﬂicting re-
sults have been reported regarding the prognosis of right-sided
colon cancer [12e17]. Therefore, the prognostic impact of tumor
location is controversial, particularly in stage IV colon cancer due to
lack of precise analysis.
In this study, we analyzed the characteristics of right- and left-
sided colon cancer and the prognostic impact of primary tumor
location and other clinical and pathological features in stage IV
colon cancer in a multicenter retrospective study.
2. Patients and methods
2.1. Patients
Data of stage IV colon cancer patients treated from January 1997
to December 2007 (n ¼ 2208) were collected from the prospective
databases of 17 referral hospitals of the Japanese Study Group for
Postoperative Follow-up of Colorectal Cancer (see Appendix).
Rectal cancer tumors were excluded from this study. The study
protocol was approved by local ethical committees.
2.2. Analysis of prognostic factors
The location of the primary tumor was divided according to the
splenic ﬂexure into the right-sided colon (cecum, ascending colon,
and transverse colon) and the left-sided colon (descending colon,Table 1
Clinical and pathological features of the study population.
All patients
Earlier/latter perioda 1132 (51.3%)/1074 (48.7%)
Age (years)b 64.1
Male sex 1266 (57.4%)
CEA (ng/dL)b 540
Tumor size (mm)b 55.0
Por, Muc, Sig 255 (12.5%)
Invasion to organ 304 (14.0%)
Nodal involvement 1681 (79.0%)
Multiple organ metastasis 624 (28.2%)
Liver metastasis 1726 (78.2%)
Lung metastasis 334 (15.1%)
Peritoneal metastasis 628 (28.5%)
Distant lymph node metastasis 195 (8.8%)
Surgical therapy
R0 resection 619 (28.0%)
Palliative primary tumor resection 1364 (61.8%)
No resection 132 (6.0%)
Other 93 (4.2%)
3-year cancer-speciﬁc survival 32.40%
CEA e carcinoembryonic antigen, Por e poorly differentiated adenocarcinoma, Muc e m
a Earlier: from January 1997 to May 2003, Latter: from June 2003 to December 2007.
b Values are expressed as means.sigmoid colon, and rectosigmoid colon). The study period was
divided into the earlier half (from January 1997 to May 2003) and
the latter half (from June 2003 to December 2007). Factors
contributing to cancer speciﬁc survival (CSS) were analyzed in a
multivariate analysis.
2.3. Statistical analysis
A paired t-test was used for comparing continuous variables and
the c2 test was used for comparing categorical data. CSS rates were
estimated by the KaplaneMeier method and compared by the log-
rank test. A multivariate analysis for factors contributing to CSS was
performed using the Cox proportional hazardsmodel. Furthermore,
to match the background features of right-sided and left-sided
colon tumors, a propensity score analysis using inverse probabil-
ity of treatment weighting (IPTW) method was performed [18]; p
values of less than 0.05 were considered to denote statistical sig-
niﬁcance. Data analyses were performed using the JMP statistical
software package (SAS Institute Inc., Cary, NC, USA) and statistical
program R (http://www.R-project.org/).
3. Results
3.1. Clinical and pathological features
Clinical and pathological features were compared between
right-sided colon and left-sided colon cancer (Table 1). Compared
with the left-sided colon tumors, the right-sided colon tumors
were more frequent in older patients and females and were larger
in size, and the histology of poorly differentiated adenocarcinoma,
mucinous adenocarcinoma, or signet-ring cell carcinomawas more
frequent in right-sided colon cancer. Right-sided colon tumors
were diagnosed at a more advanced state within stage IV disease
than left-sided colon tumors, i.e., there was more frequent invasion
to adjacent organs, involvement of regional lymph nodes, and
multiple organ metastasis. Liver metastasis was less frequent, but
peritoneal dissemination was more frequent in right-sided colon
cancer than in left-sided colon cancer. Despite the differences in
disease status, right-sided and left-sided colon tumorswere equally
treated surgically; the rates of R0 (curative) resection and palliative
primary tumor resectionwere similar between right-sided and left-Left-sided Right-sided p
679 (52.1%)/625 (47.9%) 453 (50.2%)/449 (49.8%) 0.3931
63.2 65.4 <0.0001
814 (62.4%) 452 (50.1%) <0.0001
535 547 0.9381
53.8 56.7 0.0026
120 (9.9%) 135 (16.2%) <0.0001
160 (12.4%) 144 (16.3%) 0.012
953 (75.8%) 728 (83.8%) <0.0001
341 (26.2%) 283 (31.4%) 0.0076
1062 (81.4%) 664 (73.6%) <0.0001
192 (14.7%) 142 (15.7%) 0.5123
310 (22.8%) 318 (35.3%) <0.0001
112 (8.6%) 83 (9.2%) 0.6188
0.509
378 (29.0%) 241 (26.7%)
799 (61.2%) 565 (62.6%)
72 (5.5%) 60 (6.6%)
56 (4.3%) 37 (4.1%)
35.40% 28.00% <0.0001
ucinous adenocarcinoma, Sig e signet-ring cell carcinoma.
Table 2
Factors correlated to cancer-speciﬁc survival (all patients).
n Univariate analysis Multivariate analysis
p HR 95%CI p
Perioda
Earlier/latter 1132/1074 <0.0001 1.39 1.25e1.55 <0.0001
Age (years)
70/70> 763/1444 0.0082 1.16 1.03e1.30 <0.0001
Sex
Male/female 1266/941 0.206
CEA (ng/dL)
5/5> 1267/495 <0.0001 1.21 1.06e1.39 0.0038
Location
Right-sided/left-sided 903/1305 <0.0001 1.15 1.03e1.28 0.0105
Invasion to organ
þ/ 304/1867 <0.0001 1.21 1.04e1.40 0.0138
Nodal involvement
þ/ 1681/446 <0.0001 1.51 1.32e1.74 <0.0001
Metastatic organ
Multiple/single 624/1528 <0.0001 1.36 1.16e1.61 0.0002
Liver metastasis
þ/ 1726/480 0.7313
Lung metastasis
þ/ 334/1872 <0.0001 0.91 0.77e1.09 0.3147
Peritoneal metastasis
þ/ 628/1578 <0.0001 1.37 1.19e1.57 <0.0001
Distant lymph node metastasis
þ/ 195/2011 <0.0001 1.19 0.98e1.44 0.0843
Surgical status
R0 resection/palliative primary tumor resection 619/1364 <0.0001 0.29 0.25e0.33 <0.0001
R0 resection/no resection 619/132 <0.0001 0.15 0.11e0.21 <0.0001
Palliative primary tumor resection/no resection 1364/132 <0.0001 0.52 0.39e0.71 <0.0001
HR e hazard ratio, CI e conﬁdence interval, CEA e carcinoembryonic antigen.
a Earlier: from January 1997 to May 2003, Latter: from June 2003 to December 2007.
Table 3
Factors correlated to cancer-speciﬁc survival (patients treated with R0 resection).
n Univariate analysis Multivariate analysis
p HR 95%CI p
Perioda
Earlier/latter 310/309 0.0447 1.37 1.09e1.72 0.0075
Age (years)
70/70> 191/428 0.0425 1.29 1.01e1.64 0.0435
Sex
Male/female 356/263 0.4799
CEA (ng/dL)
5/5> 378/215 0.108
Location
Right-sided/left-sided 241/378 0.5226
Tumor size (mm)
50/50> 320/285 0.7349
Histology
Por, Muc, Sig/Wel, Mod 57/557 0.0142 1.14 0.76e1.65 0.5285
Invasion to organ
þ/ 62/555 0.0065 1.52 1.06e2.12 0.0246
Nodal involvement
þ/ 452/166 0.0004 1.55 1.19e2.07 0.0012
Lymph node count
20/20> 310/292 0.1475
Metastatic organ
Multiple/single 52/565 0.0001 1.82 1.15e2.77 0.0115
Liver metastasis
þ/ 442/175 <0.0001 0.85 0.56e1.32 0.455
Lung metastasis
þ/ 40/577 0.9023
Peritoneal metastasis
þ/ 123/494 <0.0001 1.59 1.03e2.51 0.0362
Distant lymph node metastasis
þ/ 52/565 0.0059 1.28 0.78e2.10 0.3237
HRe hazard ratio, CI e conﬁdence interval, CEA e carcinoembryonic antigen, Por e poorly differentiated adenocarcinoma,Mucemucinous adenocarcinoma, Sige signet-ring
cell carcinoma, Wel e well differentiated adenocarcinoma, Mod e moderately differentiated adenocarcinoma.
a Earlier: from January 1997 to May 2003, Latter: from June 2003 to December 2007.
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Table 4
Factors correlated to cancer-speciﬁc survival (patients treated with palliative primary resection).
n Univariate analysis Multivariate analysis
p HR 95%CI p
Perioda
Earlier/Latter 711/653 <0.0001 1.40 1.23e1.59 <0.0001
Age (years)
70/70> 487/876 0.1446
Sex
Male/Female 773/590 0.0448 0.99 0.87e1.13 0.8678
CEA (ng/dL)
5/5> 1060/249 0.0089 1.23 1.04e1.46 0.0165
Location
Right-sided/Left-sided 565/799 <0.0001 1.28 1.13e1.46 <0.0001
Tumor size (mm)
50/50> 819/523 0.0317 1.17 1.03e1.34 0.0167
Histology
Por, Muc, Sig/Wel, Mod 191/1155 <0.0001 1.53 1.26e1.63 <0.0001
Invasion to organ
þ/ 199/1159 0.0532
Nodal involvement
þ/ 1103/250 <0.0001 1.44 1.21e1.71 <0.0001
Lymph node count
20/20> 445/879 <0.0001 0.70 0.61e0.81 <0.0001
Metastatic organ
Multiple/Single 488/876 <0.0001 1.32 1.13e1.54 0.0005
Liver metastasis
þ/ 1140/224 0.9373
Lung metastasis
þ/ 254/1110 0.9208
Peritoneal metastasis
þ/ 402/962 <0.0001 1.20 1.02e1.40 0.0302
Distant lymph node metastasis
þ/ 113/1251 0.0004 1.09 0.86e1.38 0.4715
HRe hazard ratio, CI e conﬁdence interval, CEA e carcinoembryonic antigen, Por e poorly differentiated adenocarcinoma,Mucemucinous adenocarcinoma, Sige signet-ring
cell carcinoma, Wel e well differentiated adenocarcinoma, Mod e moderately differentiated adenocarcinoma.
a Earlier: from January 1997 to May 2003, Latter: from June 2003 to December 2007.
Table 5
Factors correlated to cancer speciﬁc survival (patients with No resection).
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colon cancer was 28.0%, which was signiﬁcantly lower than that in
patients with left-sided colon cancer (35.4%; p < 0.0001). The
median follow-up period of the surviving patients was 36.8
months.n Univariate analysis
p
Perioda
Earlier/latter 65/65 0.0733
Age (years)
70/70> 46/86 0.9545
Sex
Male/female 86/46 0.2275
CEA (ng/dL)
5/5> 116/13 0.2548
Location
Right-sided/left-sided 60/72 0.7876
Invasion to organ
þ/ 33/74 0.996
Nodal involvement
þ/ 59/8 0.1965
Metastatic organ
Multiple/single 71/61 0.4178
Liver metastasis
þ/ 89/43 0.0793
Lung metastasis
þ/ 32/100 0.641
Peritoneal metastasis
þ/ 73/59 0.1627
Distant lymph node metastasis
þ/ 21/111 0.5475
HR e hazard ratio, CI e conﬁdence interval, CEA e carcinoembryonic antigen.
a Earlier: from January 1997 to May 2003, Latter: from June 2003 to December
2007.3.2. Prognostic impact of tumor location and other factors
Multivariate analysis for factors correlated to CSS revealed that
tumor location in the right-sided colon was independently associ-
ated with a worse CSS (Table 2). Other unfavorable prognostic
factors included treatment in the earlier half of the study period,
agemore than 70 years, high CEA level, invasion to adjacent organs,
involvement of regional lymph nodes, multiple organ metastasis,
and presence of peritoneal dissemination. Patients treated with R0
resection of both primary and metastatic tumors showed a signif-
icantly better CSS, a 71% reduction in cancer-speciﬁc death
compared to palliative primary tumor resection without resection
of metastatic tumors, and an 85% reduction compared to no
resection of both primary and metastatic tumors.
When factors correlated to CSS were analyzed separately among
patients with R0 resection, patients with palliative primary tumor
resection, and patients without any resection (Tables 3e5), right-
sided colon cancer was associated with a decreased CSS in pa-
tients with palliative primary tumor resection, but not in patients
with R0 resection or no resection. Similar results were obtained in
the cohorts matched by IPTWmethods using the propensity scores
for treatment period, age, sex, CEA level, histologic type, tumor size,
depth, regional nodal involvement, lymph node count, number of
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right-sided colon cancer were associated with a 21% increase in the
risk of cancer-speciﬁc death among patients with palliative primary
tumor resection, but not among patients with R0 resection or no
resection. Regarding other prognostic factors, size and histology of
primary tumors and lymph node count retrieved from the resected
specimens were correlated to CSS only in patients treated with
palliative primary tumor resection, but not in those with R0
resection or no resection.4. Discussion
Among patients with stage IV colon cancer, patients with right-
sided colon cancer showed a signiﬁcantly worse CSS than those
with left-sided colon cancer. Previous studies have reported con-
ﬂicting results regarding the prognosis of right-sided colon cancer
compared with left-sided colon cancer [12e17]. According to a
recent analysis of a large number of colon cancer using the Sur-
veillance, Epidemiology, and End Results database, prognosis of
right-sided colon cancer did not differ from that of left-sided colon
cancer in stage I, and it was rather better in stage II, and worse in
stage III and stage IV [13,15]. In our previous analysis of stage IeIII
colon cancer, CSS of right-sided colon cancer was signiﬁcantly
better than that of left-sided colon cancer among patients with
poorly differentiated adenocarcinoma, mucinous adenocarcinoma,
and signet-ring cell carcinoma, but not among patients with well or
moderately differentiated adenocarcinoma [17]. Therefore, the
prognostic signiﬁcance of tumor location appears to differ between
patient subgroups with different backgrounds such as stage andFig. 1. Adjusted hazard ratio for cancer-speciﬁc mortality. Hazard ratio (HR) with 95%
conﬁdence intervals (CI) for cancer-speciﬁc mortality comparing right-sided colon
cancer relative to left-sided colon cancer adjusted by propensity scores for treatment
period, age, sex, CEA level, histologic type, tumor size, depth, regional nodal involve-
ment, lymph node count, number of metastatic organs, and localization of distant
metastasis. R0 e patients treated with R0 resection, Palliative resection e patients
treated with primary tumor resection without resection of distant metastasis, No
resection e patients treated without resection of primary and metastatic tumors, LB e
lower bound, UB e upper bound.histologic type. To the best of our knowledge, this is the ﬁrst study
to precisely compare the prognosis and clinicopathological features
of stage IV right-sided and left-sided colon cancer.
Right-sided colon cancer was associated with a more advanced
stage within stage IV disease, such as larger tumor size, invasion to
adjacent organs, involvement of regional lymph nodes, and multi-
ple organ metastases; these features of stage IV right-sided colon
cancer are consistent with previous reports on stage IeIII colon
cancer [15]. Advancement of disease may be a result of delay in the
diagnosis of right-sided colon cancer. Patients with right-sided
colon cancer were 2 years older than those with left-sided colon
cancer. In general, right-sided colon cancer is considered to be less
symptomatic than left-sided colon cancer because liquid stools in
the right-sided colon less frequently cause tumor-related symp-
toms, such as obstruction and bleeding, and thus, they tend to be
diagnosed at a more advanced stage of disease [10]. Of course, the
advanced stage of cancer may contribute to the worse prognosis of
right-sided colon cancer in this study; however, multivariate
analysis revealed that tumor location in the right-sided colon was
associated with a worse CSS independent of such adverse features,
which may suggest a particular biological aggressiveness of right-
sided colon cancer. Right-sided and left-sided colon cancer can
only be compared through observational studies and differences in
background features are inevitable. Therefore, we performed a
propensity score analysis using the IPTWmethod [18] in addition to
Cox proportional hazards model analysis to assess whether the
differences in background features between right-sided and left-
sided colon cancer are due to the aggressiveness of right-sided
colon tumors.
The colonic segment proximal to the splenic ﬂexure (right-sided
colon) and the distal segment (left-sided colon) are of embryo-
logically different origins [7]; recently, the carcinogenetic pathways
of the proximal and distal colorectal cancers have been suggested
to differ and shown to have diverse clinical, pathological, and bio-
logical features [8,10]. Right-sided colon cancer are characterized
by a high frequency of microsatellite instability (MSI) and BRAF
mutation [19e22]; BRAF mutation has been shown to correlate
with aworse prognosis [19,20,22]. On the other hand, MSI has been
shown to have a favorable impact on the prognosis of curatively
resected stage II colorectal cancer [21]; however, a recent study has
demonstrated that MSI is associated with poorer survival in pa-
tients with metastatic colorectal cancer in association with BRAF
mutation, which is not the case at earlier stages of the disease [22].
In the present study, no data regarding genetic changes including
MSI or BRAF were available, which is one of its major limitations,
although these genetic changes may have contributed to the worse
prognosis of stage IV right-sided colon cancer. Poorly differentiated
adenocarcinoma, mucinous adenocarcinoma, and signet-ring cell
carcinoma, which are also characteristic in colorectal cancer with
MSI or BRAF mutation [20,23,24], were signiﬁcantly more frequent
in stage IV right-sided colon cancer than left-sided colon cancer in
this study. Furthermore, liver metastasis was signiﬁcantly less
frequent and peritoneal dissemination was more frequent in stage
IV right-sided colon cancer than in left-sided colon cancer; MSI and
BRAF mutation have also been reported to be associated with less
frequent liver metastasis and more frequent peritoneal dissemi-
nation, respectively [22].
Surgical treatment signiﬁcantly affected the prognosis; patients
with R0 resection showed the best prognosis followed by those
treated with palliative primary tumor resection and those without
resection of both primary and metastatic tumors showed the worst
prognosis. Therefore, we separately analyzed the prognostic impact
of tumor location in each treatment subgroup. Right-sided colon
cancer showed a signiﬁcantly worse prognosis in patients treated
with palliative primary tumor resection, but not in patients with R0
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therapy inﬂuences the prognostic impact of primary tumor location
is unclear. For R0 patients, radicality of surgical resection may
mitigate the difference in biological aggressiveness between right-
sided and left-sided colon cancer; on the other hand, for patients
treated with palliative primary tumor resection, the difference in
the aggressiveness of remaining metastases originating from right-
sided and left-sided colon cancer may have resulted in a difference
in prognosis. Meguid et al. reported that for stage IIeIV colon
cancers, the negative prognostic impact of tumor location in the
right-sided colon increases with advancing stage; further, they
reported a relatively favorable prognosis of right-sided colon can-
cer compared with left-sided colon cancer in stage II and the
opposite in stage IV [13]. A similar explanation may be possible in
the present study because the stage of disease was more advanced
in patients with palliative resection than in those with R0 resection
(data not shown). For patients with no resection, the extra “harm”
caused by the presence of both primary andmetastatic tumors may
have obscured the differences in aggressiveness of right-sided and
left-sided colon cancer.
In conclusion, right-sided colon cancer was diagnosed at a more
advanced state within stage IV disease and showed a worse prog-
nosis than left-sided colon cancer, suggesting that stage IV right-
sided colon cancer is biologically more aggressive than left-sided
colon cancer. The underlying mechanism must be elucidated by
determining and comparing the biological proﬁles including ge-
netic changes in right-sided and left-sided colon cancer.
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